Qinecsa Solutions announce acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions
Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, has announced its acquisition of Insife ApS, a Danish-based software, technology and consultancy firm specialising in developing pharamacovigilance platforms.
The company says this acquisition is in alignment with its vision, playing a ‘crucial role’ in its pursuit to become a leading provider of digital pharmacoviglance solutions.
Qinecsa offers solutions that integrate technology and scientific expertise. Through advanced platforms like Reportum and CVW, Qinecsa says it helps life science companies to capture, manage, and evaluate drug safety data with efficiency and accuracy throughout the drug life cycle.
Insife is a global pharmacovigilance software, technology, and consultancy company that delivers innovation, insights, and solutions to pharmaceutical companies and regulatory agencies around the world. Its HALOPV platform is considered a ‘safety database’ with multivigilance capabilities and more, as it covers the end-to-end management of PV processes.
HALOPV is available as an enterprise-grade technology, as well as in a multi-tenant SaaS offering for cost-effective uses according to the company.
Qinecsa says the acquisition of Insife represents a strategic move to strengthen its position as a leading provider of pharmacovigilance solutions and technologies.
The company claims that bringing together both brands understanding of the pharmaceutical industry and regulatory environment will offer an enhanced suite of pharmacovigilance service and technologies to support pharmaceutical companies and regulatory agencies worldwide.
“We are thrilled to welcome Insife into the Qinecsa family. This marks a significant milestone and is a natural fit, reinforcing our position as a unique pharmacovigilance provider. By integrating Insife's cutting-edge automation technology, specialized knowledge, and consultancy services into our offerings, we are poised to deliver even greater value and support to our customers globally,” said John Gillie, CEO of Qinecsa Solutions.
Martin Holm-Petersen, CEO of Insife added: “"We are excited about the opportunities that lie ahead as an entity within Qinecsa Solutions. Joining forces with Qinecsa is a strategic move for the company, its people, and customers. We will leverage the platform to expand our global footprint and better support our clients with HALOPV in combination with Qinecsa’s best-of-breed technology solutions and services for all areas and life cycles of drugs. We will be able to underline our position as the number one technology provider for pharmacovigilance, expand our reach and capabilities, while driving positive outcomes for the pharmaceutical industry."